Top compounds associated with response to CILP


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0061 0.9
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.0062 0.9
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.0062 0.9
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.006 0.9
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0097 0.9
mRNA GSK525762A CTRPv2 pan-cancer AAC 0.0054 0.9
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.0058 0.9
mRNA PX-12 CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA AUY922 GDSC1000 pan-cancer AAC -0.0061 0.9
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.0051 0.9
Download CSV